EUVIMEDOpdag EUVIMED
Open access

GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling

Yajie Peng, Hongyan Lei, Jiahui Zhao, Huajuan Wang, Zheng Luo, Dixin Wang, Shujun Shi, Tianyi Wang, Jin Li, Zhiqing Pang, Bo Wang, Xuelian Xiong

International Journal of Biological Sciences · 2025-10-27 · 21 (15) · 6997-7012

DOI: 10.7150/ijbs.123784 ↗

At a glance

Journal article in International Journal of Biological Sciences, published on 2025-10-27. Written by Yajie Peng and 11 co-authors. Institution: Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan Univ…. Major MEDLINE topics: Hepatic Stellate Cells, Smad2 Protein, Growth Differentiation Factor 10, Transforming Growth Factor beta. Cited 6 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Liver fibrosis has emerged as the primary determinant of outcomes in metabolic dysfunction-associated steatohepatitis (MASH). Quiescent hepatic stellate cells (HSCs) differentiate into activated HSCs or myofibroblasts, which drives liver fibrosis and contribute to the progressive loss of hepatic function. MASH with progressive fibrosis lacks effective therapies due to incomplete understanding of HSCs regulation. Here, we identify growth differentiation factor 10 (GDF10) as a master regulator of HSCs quiescence that ameliorates fibrosis through shifting HSC functions to restore HSC balance of transcriptional and metabolic reprogramming. Single-cell RNA sequencing revealed HSC-specific Gdf10 expression inversely correlated with fibrotic activation. In murine models of diet-induced MASH and CCl4-induced fibrosis, AAV-mediated Gdf10 overexpression reduced collagen deposition, serum ALT/AST, and fibrogenic gene expression without perturbing glucose or lipid metabolism. Mechanistically, GDF10 competitively bound TGF-β receptor 2 (TβR2), inhibiting SMAD2/3 phosphorylation and nuclear translocation, ultimately suppressing TGFβ1-driven extracellular matrix production, and reversing the activated HSCs phenotype and their hypermetabolic states. Leveraging this pathway, we developed liver-targeted lipid nanoparticles (LNPs) encapsulating mGdf10 mRNA, which selectively delivered Gdf10 to HSCs, reversed fibrosis in multiple animal models. Clinically, GDF10 expression correlated with fibrosis severity in human cirrhotic livers. Our findings establish GDF10 as a dual-function modulator of TGF-β signaling and HSC metabolism, offering a targeted therapeutic strategy for liver fibrosis.

Subjects

MeSH terms (MEDLINE)

Hepatic Stellate CellsSmad2 ProteinGrowth Differentiation Factor 10Transforming Growth Factor betaFatty LiverAnimalsMiceSignal TransductionLiver CirrhosisHumansMaleMice, Inbred C57BL

Author keywords

GDF10HSCsMASHliver fibrosis

Substances

Smad2 ProteinGrowth Differentiation Factor 10Transforming Growth Factor beta

Authors and institutions

  • Ministry of Education Key Laboratory of Metabolism and Molecular Medicine, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, 200020, Shanghai, China.
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, 200438, Shanghai, China.
  • Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, 201203, Shanghai, China.
  • Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.

Cite

APA

Peng, Y., Lei, H., Zhao, J., Wang, H., Luo, Z., Wang, D., Shi, S., Wang, T., Li, J., Pang, Z., Wang, B., & Xiong, X. (2025). GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling. International Journal of Biological Sciences, 21(15), 6997-7012. https://doi.org/10.7150/ijbs.123784

Vancouver

Peng Y, Lei H, Zhao J, Wang H, Luo Z, Wang D, et al. GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling. International Journal of Biological Sciences. 2025;21(15):6997-7012. doi:10.7150/ijbs.123784

BibTeX
@article{Peng2025,
  author = {Peng, Yajie and Lei, Hongyan and Zhao, Jiahui and Wang, Huajuan and Luo, Zheng and Wang, Dixin and Shi, Shujun and Wang, Tianyi and Li, Jin and Pang, Zhiqing and Wang, Bo and Xiong, Xuelian},
  title = {GDF10 attenuates MASH progression by restoring quiescent hepatic stellate cells via competitive inhibition of TGF-β/SMAD2 signaling},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {15},
  pages = {6997--7012},
  doi = {10.7150/ijbs.123784}
}
Start for free →